MANSFIELD; Robert K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MANSFIELD; Robert K..The latest application filed is for "polymorphic form of tg02 for treating cancer".

Company Profile

3.4.18

MANSFIELD; Robert K. - San Marcos CA
Mansfield; Robert K. - Carlsbad CA US
Mansfield; Robert K. - Dallas TX
Mansfield; Robert K. - Carisbad CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymorphic Form Of Tg02 For Treating Cancer App 20200262843 - MANSFIELD; Robert K. ; et al.	2020-08-20
Polymorphic form of TG02 Grant 10,544,162 - Mansfield , et al. Ja	2020-01-28
Polymorphic form of TG02 App 20190055263 - Mansfield; Robert K. ; et al.	2019-02-21
Solid state forms of macrocyclic kinase inhibitors Grant 9,120,815 - Mansfield , et al. September 1, 2	2015-09-01
Solid State Forms Of Macrocyclic Kinase Inhibitors App 20130150378 - Mansfield; Robert K. ; et al.	2013-06-13
Methods And Compositions For The Treatment Of Cancer, Tumors, And Tumor-related Disorders App 20130084281 - Estok; Thomas M. ; et al.	2013-04-04
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders Grant 8,247,423 - Estok , et al. August 21, 2	2012-08-21
Therapies For Treating Cancer Using Combinations Of Cox-2 Inhibitors And Anti-her2(erbb2) Antibodies Or Combinations Of Cox-2 Inhibitors And Her2(erbb2) Receptor Tyrosine Kinase Inhibitors App 20120052061 - Estok; Thomas M. ; et al.	2012-03-01
Therapies For Treating Cancer Using Combinations Of Cox-2 Inhibitors And Aromatase Inhibitors Or Combinations Of Cox-2 Inhibitors And Estrogen Receptor Antagonists App 20120015919 - Estok; Thomas M. ; et al.	2012-01-19
COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL InHIBITORS OF EGFR [ErbB1] AND HER-2 [ErbB2] App 20110306572 - Estok; Thomas M. ; et al.	2011-12-15
System and method for comprehensive management of company equity structures and related company documents with financial and human resource system integration App 20110106676 - Levi; Andrew E. ; et al.	2011-05-05
Oral Pharmaceutical Formulations And Methods For Producing And Using Same App 20100063020 - Mansfield; Robert K. ; et al.	2010-03-11
System and method for comprehensive management of company equity structures and related company documents withfinancial and human resource system integration App 20090293104 - Levi; Andrew E. ; et al.	2009-11-26
Phospholipid-based Pharmaceutical Formulations And Methods For Producing And Using Same App 20090238880 - Ulm; Edgar H. ; et al.	2009-09-24
Methods and Compositions for the Treatment of Cancer, Tumors, and Tumor-Related Disorders App 20090017024 - Estok; Thomas M. ; et al.	2009-01-15
Compositions Containing Ansamycin App 20070129342 - Mansfield; Robert K. ; et al.	2007-06-07
Phospholipid-based pharmaceutical formulations and methods for producing and using same App 20060228405 - Ulm; Edgar H. ; et al.	2006-10-12
Drug formulations having long and medium chain triglycerides App 20060148776 - Ulm; Edqar H. ; et al.	2006-07-06
Oral pharmaceutical formulations and methods for producing and using same App 20060067953 - Mansfield; Robert K. ; et al.	2006-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.